Practical Use of the Pessary
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
What Is a Hysterectomy?
Greenwich Hospital What is a Hysterectomy? PATIENT/FAMILY INFORMATION SHEET What is a Hysterectomy? A hysterectomy is the surgical removal of the uterus (womb). Sometimes the fallopian tubes, ovaries, and cervix are removed at the same time that the uterus is removed. When the ovaries and both tubes are removed, this is called a bilateral salpingo- oophorectomy. There are three types of hysterectomies: • A complete or total hysterectomy, which is removal of the uterus and cervix. • A partial or subtotal hysterectomy, which is removal of the upper portion of the uterus, leaving the cervix in place. • A radical hysterectomy, which is removal of the uterus, cervix, the upper part of the vagina, and supporting tissue. If you have not reached menopause yet, a hysterectomy will stop your monthly periods. You also will not be able to get pregnant. How is a hysterectomy performed? A hysterectomy can be performed in three ways: • Abdominal hysterectomy: The surgeon will make a cut, or incision, in your abdomen either vertically (up and down) in the middle of the abdomen below the umbilicus (belly button); or horizontally (side ways) in the pelvic area. The horizontal incision is sometimes referred to as a “bikini” incision and is usually hidden by undergarments. • Vaginal hysterectomy: The surgeon goes through the vagina and the incision is on the inside of the vagina, not on the outside of the body. • Laparoscopically assisted vaginal hysterectomy: This involves using a small, telescope-like device called a laparoscope, which is inserted into the abdomen through a small cut. This brings light into the abdomen so that the surgeon can see inside. -
Perceived Gynecological Morbidity Among Young Ever-Married Women
Perceived Gynecological Morbidity among Young ever-married Women living in squatter settlements of Karachi, Pakistan Pages with reference to book, From 92 To 97 Fatima Sajan,Fariyal F. Fikree ( Department of Community Health Sciences, The Aga Khan University, Karachi, Pakistan. ) Abstract Background: Community-based information on obstetric and gynecological morbidity in developing countries is meager and nearly non-existent in Pakistan. Objectives: To estimate the prevalence of specific gynecological morbidities and investigate the predictors of pelvic inflammatory disease Methods: Users and non-users of modem contraceptives were identified from eight squatter settlements of Karachi, Pakistan and detailed information on basic demographics, contraceptive use, female mobility, decision-making and gynecological morbidities were elicited. Results: The perceived prevalence of menstrual disorders were 45.3%, uterine prolapse 19.1%, pelvic inflammatory disease 12.8% and urinary tract infection 5.4%. The magnitude of gynecological morbidity was high with about 55% of women reporting at least one gynecological morbidity though fewer reported at least two gynecological morbidities. Significant predictors of pelvic inflammatory disease were intrauterine contraceptive device users (OR = 3.1; 95% CI 1.7- 5.6), age <20 years (OR = 2.3; 95% CI 1.1 - 4.8) and urban life style (OR = 2.1; 95% CI 1.0-4.6). Conclusion: There is an immense burden of reproductive ill-health and a significant association between eyer users of intrauterine contraceptive device and pelvic inflammatory disease. We therefore suggest improvement in the quality of reproductive health services generally, but specifically for family planning services (JPMA 49:92, 1999). Introduction Gynecological morbidity has been defined as structural and functional disorders of the genital tract which are not directly related to pregnancy, delivery and puerperium. -
OVESTIN PESSARY (0.5Mg)
NEW ZEALAND DATA SHEET 1. OVESTIN PESSARY (0.5mg) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each pessary contains 0.5 mg Estriol. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Pessary 0.5 mg - white, torpedo formed pessary. One pessary (2.5 g weight) contains 0.5 mg oestriol. Length 26.5 mm; largest diameter 14 mm. 4. CLINICAL PARTICULARS 4.1 Therapeutic indications Atrophy of the lower urogenital tract related to oestrogen deficiency, notably • for the treatment of vaginal complaints such as dyspareunia, dryness and itching. • for the prevention of recurrent infections of the vagina and lower urinary tract. • in the management of micturition complaints (such as frequency and dysuria) and mild urinary incontinence. Pre- and postoperative therapy in postmenopausal women undergoing vaginal surgery. A diagnostic aid in case of a doubtful atrophic cervical smear. 4.2 Dose and method of administration Dosage OVESTIN is an oestrogen-only product that may be given to women with or without a uterus. Atrophy of the lower urogenital tract 1 pessary per day for the first weeks, followed by a gradual reduction, based on relief of symptoms, until a maintenance dosage (e.g. 1 pessary twice a week) is reached. Pre- and post-operative therapy in postmenopausal women undergoing vaginal surgery 1 pessary per day in the 2 weeks before surgery; 1 pessary twice a week in the 2 weeks after surgery. A diagnostic aid in case of a doubtful atrophic cervical smear 1 pessary on alternate days in the week before taking the next smear. Administration OVESTIN pessaries should be inserted intravaginally before retiring at night. -
UK Clinical Guideline for Best Practice in the Use of Vaginal Pessaries for Pelvic Organ Prolapse
UK Clinical Guideline for best practice in the use of vaginal pessaries for pelvic organ prolapse March 2021 Developed by members of the UK Clinical Guideline Group for the use of pessaries in vaginal prolapse representing: the United Kingdom Continence Society (UKCS); the Pelvic Obstetric and Gynaecological Physiotherapy (POGP); the British Society of Urogynaecology (BSUG); the Association for Continence Advice (ACA); the Scottish Pelvic Floor Network (SPFN); The Pelvic Floor Society (TPFS); the Royal College of Obstetricians and Gynaecologists (RCOG); the Royal College of Nursing (RCN); and pessary users. Funded by grants awarded by UKCS and the Chartered Society of Physiotherapy (CSP). This guideline was completed in December 2020, and following stakeholder review, has been given official endorsement and approval by: • British Association of Urological Nurses (BAUN) • International Urogynecological Association (IUGA) • Pelvic Obstetric and Gynaecological Physiotherapy (POGP) • Scottish Pelvic Floor Network (SPFN) • The Association of Continence Advice (ACA) • The British Society of Urogynaecology (BSUG) • The Pelvic Floor Society (TPFS) • The Royal College of Nursing (RCN) • The Royal College of Obstetricians and Gynaecologists (RCOG) • The United Kingdom Continence Society (UKCS) Review This guideline will be due for full review in 2024. All comments received on the POGP and UKCS websites or submitted here: [email protected] will be included in the review process. 2 Table of Contents Table of Contents ................................................................................................................................ -
Pessary for Management of Pelvic Organ Prolapse
Pessary for management of Pelvic Organ Prolapse Cathy Davis Clinical Nurse Specialist Department of Urogynaecology King’s College Hospital, London Definition of Prolapse The descent of one or more of the anterior vaginal wall, posterior vaginal wall, uterus (cervix) or vaginal vault (cuff scar after hysterectomy). The presence of any such sign should be correlated with relevant POP symptoms. (Haylen et al 2016) Risk Factors • Increased intra-abdominal pressure • Chronic cough • Chronic constipation • Weight lifting • Presence of abdominal tumours - fibroids & ovarian cysts • High impact exercise • Age/ Menopause • Obesity Risk Factors contd.... • Smoking • Multiparity • Congenital weakness – rare; due to deficiency in collagen metabolism • Injury to pelvic floor muscles • Iatrogenic/ pelvic surgery - hysterectomy Symptoms of POP • May be asymptomatic – a small amount of prolapse can often be normal • Sensation of a lump or bulge " coming down" - most common • Backache • Heaviness • Dragging or discomfort inside the vagina – often worse on standing /sitting for prolonged periods • Seeing a lump or bulge Symptoms of POP contd.... • Bladder / Urinary symptoms -Frequency -Difficulty initiating voids, low-flow, incomplete bladder emptying -Leakage on certain movements or when lifting heavy objects -Recurrent urinary tract infections • Bowel symptoms -Constipation - Incomplete bowel emptying - May have to digitate to defecate/use aides • Symptoms related to Sex – uncomfortable, lack of sensation Diagnosis of Prolapse • Vaginal examination • -
Uterine Prolapse
Uterine prolapse Definition Uterine prolapse is falling or sliding of the uterus from its normal position in the pelvic cavity into the vaginal canal. Alternative Names Pelvic relaxation; Pelvic floor hernia Causes The uterus is normally supported by pelvic connective tissue and the pubococcygeus muscle, and held in position by special ligaments. Weakening of these tissues allows the uterus to descend into the vaginal canal. Tissue trauma sustained during childbirth, especially with large babies or difficult labor and delivery, is typically the cause of muscle weakness. The loss of muscle tone and the relaxation of muscles, which are both associated with normal aging and a reduction in the female hormone estrogen, are also thought to play an important role in the development of uterine prolapse. Descent can also be caused by a pelvic tumor, however, this is fairly rare. Uterine prolapse occurs most commonly in women who have had one or more vaginal births, and in Caucasian women. Other conditions associated with an increased risk of developing problems with the supportive tissues of the uterus include obesity and chronic coughing or straining. Obesity places additional strain on the supportive muscles of the pelvis, as does excessive coughing caused by lung conditions such as chronic bronchitis and asthma. Chronic constipation and the pushing associated with it causes weakness in these muscles. Symptoms z Sensation of heaviness or pulling in the pelvis z A feeling as if "sitting on a small ball" z Low backache z Protrusion from the vaginal opening (in moderate to severe cases) z Difficult or painful sexual intercourse Exams and Tests A pelvic examination (with the woman bearing down) reveals protrusion of the cervix into the lower part of the vagina (mild prolapse), past the vaginal introitus/opening (moderate prolapse), or protrusion of the entire uterus past the vaginal introitus/opening (severe prolapse). -
Combi Soft Gel Pessary & External Cream
Combi Soft Gel Pessary Canesten & External Cream 500mg vaginal capsule & 2% w/w cream Clotrimazole Read all of this leaflet carefully because it contains important To treat internal thrush, your doctor may recommend that you use the information for you. pessary without the help of an applicator. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. HOW TO USE CANESTEN® COMBI • This medicine has been prescribed for you. Do not give it to anyone else 3. under any circumstances. The Soft Gel Pessary: • If you have any unusual effects after using this product, tell your doctor. Unless directed otherwise by your doctor, the Soft Gel Pessary should be inserted as high as possible into the vagina, preferably before going to sleep IN THIS LEAFLET at night for convenient and comfortable treatment. Wash your hands before removing the foil from the blister pack and again 1. What is Canesten Combi and what is it used for? afterwards when you have used the applicator. 2. Before you use Canesten Combi 3. How to use Canesten Combi 1. Remove the applicator from the packaging. Pull out the plunger A until it 4. Possible side effects stops. Remove the pessary from the foil blister pack and place firmly into the 5. How to store Canesten Combi applicator B. 6. Further information 1. WHAT IS CANESTEN® COMBI AND WHAT IS IT USED FOR? Canesten Combi Soft Gel Pessary & External Cream is a full course of treatment for vaginal thrush (candidiasis) because it treats both the internal cause and external symptoms. -
U.S. Medical Eligibility Criteria for Contraceptive Use, 2010
Morbidity and Mortality Weekly Report www.cdc.gov/mmwr Early Release May 28, 2010 / Vol. 59 U.S. Medical Eligibility Criteria for Contraceptive Use, 2010 Adapted from the World Health Organization Medical Eligibility Criteria for Contraceptive Use, 4th edition department of health and human services Centers for Disease Control and Prevention Early Release CONTENTS The MMWR series of publications is published by the Office of Surveillance, Epidemiology, and Laboratory Services, Centers for Introduction .............................................................................. 1 Disease Control and Prevention (CDC), U.S. Department of Health Methods ................................................................................... 2 and Human Services, Atlanta, GA 30333. How to Use This Document ......................................................... 3 Suggested Citation: Centers for Disease Control and Prevention. [Title]. MMWR Early Release 2010;59[Date]:[inclusive page numbers]. Using the Categories in Practice ............................................... 3 Recommendations for Use of Contraceptive Methods ................. 4 Centers for Disease Control and Prevention Contraceptive Method Choice .................................................. 4 Thomas R. Frieden, MD, MPH Director Contraceptive Method Effectiveness .......................................... 4 Peter A. Briss, MD, MPH Unintended Pregnancy and Increased Health Risk ..................... 4 Acting Associate Director for Science Keeping Guidance Up to Date ................................................... -
Uterine Prolapse Treatment Without Hysterectomy
Uterine Prolapse Treatment Without Hysterectomy Authored by Amy Rosenman, MD Can The Uterine Prolapse Be Treated Without Hysterectomy? A Resounding YES! Many gynecologists feel the best way to treat a falling uterus is to remove it, with a surgery called a hysterectomy, and then attach the apex of the vagina to healthy portions of the ligaments up inside the body. Other gynecologists, on the other hand, feel that hysterectomy is a major operation and should only be done if there is a condition of the uterus that requires it. Along those lines, there has been some debate among gynecologists regarding the need for hysterectomy to treat uterine prolapse. Some gynecologists have expressed the opinion that proper repair of the ligaments is all that is needed to correct uterine prolapse, and that the lengthier, more involved and riskier hysterectomy is not medically necessary. To that end, an operation has been recently developed that uses the laparoscope to repair those supporting ligaments and preserve the uterus. The ligaments, called the uterosacral ligaments, are most often damaged in the middle, while the lower and upper portions are usually intact. With this laparoscopic procedure, the surgeon attaches the intact lower portion of the ligaments to the strong upper portion of the ligaments with strong, permanent sutures. This accomplishes the repair without removing the uterus. This procedure requires just a short hospital stay and quick recovery. A recent study from Australia found this operation, that they named laparoscopic suture hysteropexy, has excellent results. Our practice began performing this new procedure in 2000, and our results have, likewise, been very good. -
Pessary Information
est Ridge obstetrics & gynecology, LLP 3101 West Ridge Road, Rochester, NY 14626 1682 Empire Boulevard, Webster, NY 14580 www.wrog.org Tel. (585) 225‐1580 Fax (585) 225‐2040 Tel. (585) 671‐6790 Fax (585) 671‐1931 USE OF THE PESSARY The pessary is one of the oldest medical devices available. Pessaries remain a useful device for the nonsurgical treatment of a number of gynecologic conditions including pelvic prolapse and stress urinary incontinence. Pelvic Support Defects The pelvic organs including the bladder, uterus, and rectum are held in place by several layers of muscles and strong tissues. Weaknesses in this tissue can lead to pelvic support defects, or prolapse. Multiple vaginal deliveries can weaken the tissues of the pelvic floor. Weakness of the pelvic floor is also more likely in women who have had a hysterectomy or other pelvic surgery, or in women who have conditions that involve repetitive bearing down, such as chronic constipation, chronic coughing or repetitive heavy lifting. Although surgical repair of certain pelvic support defects offers a more permanent solution, some patients may elect to use a pessary as a very reasonable treatment option. Classification of Uterine Prolapse: Uterine prolapse is classified by degree. In first‐degree uterine prolapse, the cervix drops to just above the opening of the vagina. In third‐degree prolapse, or procidentia, the entire uterus is outside of the vaginal opening. Uterine prolapse can be associated with incontinence. Types of Vaginal Prolapse: . Cystocele ‐ refers to the bladder falling down . Rectocele ‐ refers to the rectum falling down . Enterocele ‐ refers to the small intestines falling down . -
Pelvic Organ Prolapse
Pelvic Organ Prolapse An estimated 34 million women worldwide are affected by pelvic organ prolapse (POP). POP is found to be a difficult topic for women to talk about. POP is essentially a form of herniation of the vaginal wall due to laxity of the collagen, fascia and muscles within the pelvis and surrounding the vagina. Pelvic Organ Prolapse incudes: • Cystocele: bladder herniation through the upper vaginal wall. • Rectocele: rectum bulging through the lower vaginal wall. • Enterocele: bowel bulging through the deep vaginal wall. • Uterine prolapse: uterus falling into the vaginal wall. Detection and Diagnosis Common causes and symptoms of pelvic organ prolapse may be the sensation of a mass bulging from the vaginal region and a feeling of pelvic heaviness as well as vaginal irritation. The prolapse may occur at the level of the bladder bulging through the vagina or the rectum bulging through the bottom of the vagina. For that reason, we describe it as a herniating process through the vaginal wall. Once the symptoms are established, a proper history and physical should be obtained from a specialized physician/surgeon. Common causes we know are pregnancy, especially with vaginal childbirth. Vaginal childbirth increases a women’s risk of prolapse as well as urinary incontinence greater than an elective C-section. An emergency C-section would then cause a risk factor three times higher in terms of urinary incontinence as well as vaginal vault prolapse. The collagen-type tissue within the patient’s pelvis is a known cause of a patient being prone to vaginal vault prolapse as well as urinary incontinence. -
Histopathology Findings of the Pelvic Organ Prolapse
Review Histopathology fndings of the pelvic organ prolapse FERNANDA M.A. CORPAS1, ANDRES ILLARRAMENDI2, FERNANDA NOZAR3, BENEDICTA CASERTA4 1 Asistente Clínica Ginecotocológica A CHPR, 2 Residente de Ginecología, Clínica Ginecotocológica A CHPR, 3 Profesora Adjunta Clínica Ginecotocológica A CHPR, 4 Jefa del servicio de Anatomía Patológica del CHPR, Presidenta de la Sociedad de Anatomía Patológica del Uruguay, Centro Hospitalario Pereira Rossell (Chpr), Montevideo, Uruguay Abstract: Pelvic organ prolapse is a benign condition, which is the result of a weakening of the different components that provide suspension to the pelvic foor. Surgical treatment, traditionally involve a vaginal hysterectomy, although over the last few decades the preservation of the uterus has become more popular. The objective of the paper is to analyze the characteristics of those patients diagnosed with pelvic organ prolapse, whose treatment involved a vaginal hysterectomy and its correlation to the histopathological characteristics. Retrospective, descriptive study. Data recovered from the medical history of patients that underwent surgical treatment for pelvic organ prolapse through vaginal hysterectomy, were analyzed in a 2 years period, in the CHPR, and compared to the pathology results of the uterus. At the level of the cervix, 58,2% presented changes related to the prolapse (acantosis, para and hyperqueratosis) and 43,6% chronic endocervicitis. Findings in the corpus of the uterus were 58,2% atrophy of the endometrium, 21% of endometrial polyps and 30.9% leiomiomas and 1 case of simple hyperplasia without cellular atypias. No malignant lesions were found. The pathology results of the uterus reveal the presence of anatomical changes related to the pelvic organ prolapse and in accordance to the age of the patient, as well as associated pathologies to a lesser extent.